By Bruce Chabner, Jr., Thomas Lynch, Dan Longo
A CONCISE but THOROUGH evaluation OF THE drugs AND ways utilized in melanoma CARE--BACKED through THE AUTHORITY OF HARRISON'S
Harrison's handbook of Oncology is a carry-anywhere consultant to the care of sufferers with melanoma. superior by way of the most recent released effects, this necessary scientific significant other positive aspects various tables and succinct, outline-style textual content that places vital details at your fingertips. you will discover content material that is going past the remedy of fundamental or metastatic disorder to surround the therapy of all healing complications.
The commencing sections of Harrison's handbook of Oncology are dedicated to the sessions of brokers used to regard melanoma and studies their pharmacology and mechanisms of motion. This part is through a close dialogue of the prognosis, staging, and therapy of all significant varieties of melanoma. there's a powerful specialise in symptom administration and issues of therapy, together with soreness, nausea and vomiting, anemia, febrile neutropenia, metabolic emergencies, thrombosis, mental concerns, and end-of-life care.
Read or Download Harrisons Manual of Oncology PDF
Best oncology books
Views on melanoma Care is a different selection of insights from participants, in keeping with their particular services and adventure. It presents various views on melanoma care that could encourage the readers and inspire top of the range care via an more suitable realizing of the sufferers' wishes and the carers' talents.
A CONCISE but THOROUGH review OF THE medicinal drugs AND ways utilized in melanoma CARE--BACKED through THE AUTHORITY OF HARRISON'S Harrison's handbook of Oncology is a carry-anywhere consultant to the care of sufferers with melanoma. superior through the most recent released effects, this necessary medical better half good points a variety of tables and succinct, outline-style textual content that places very important details at your fingertips.
Perry’s The Chemotherapy resource e-book, now in its 5th variation, offers details at the collection of chemotherapeutic brokers, using mixture chemotherapy, and the toxicity of person drugs. geared up through web site, this is often the single ebook of its type to concentration strictly at the medical perform of chemotherapy, and is intended to function a “one-stop store” for info on number of chemotherapeutic brokers, remedy outlines, grading of unwanted effects, and dose amendment.
- Methods of Cancer Diagnosis, Therapy and Prognosis: Brain Cancer (Methods of Cancer Diagnosis, Therapy and Prognosis, Volume 8)
- Gastrointestinal Oncology
- Berries and Cancer Prevention
- Vaccines Against Virally Induced Cancers (Novartis Foundation Symposia)
Extra resources for Harrisons Manual of Oncology
2012; 367: 1694–1703. 27. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004; 351: 2817. 28. Marchionni L, Wilson RF, Wolff AC, et al. Systematic review: gene expression profiling assays in early-stage breast cancer. Ann Intern Med. 2008; 148: 358–369. Review. 29. Nagaraj G, Ma CX. Adjuvant chemotherapy decisions in clinical practice for early-stage node-negative, estrogen receptor-positive, HER2-negative breast cancer: challenges and considerations.
Bolus and infusion doses vary according to other drugs in the combination regimen and the use of radiation therapy concomitantly. The parent drug is not readily bioavailable by the oral route due to rapid first-pass metabolism in the liver. Following intravenous administration, plasma concentrations of 5-FU decline rapidly, with a t1/2 of 10 min, due to the conversion of 5-FU to dihydro-5-FU by DPD. Intracellular concentrations of 5-FdUMP and other nucleotides build rapidly, and decay with a half-life of approximately 4 h.
N Engl J Med. 2013; 368: 1101–1110. 13. Sideras K, Ingle JN, Ames MM, et al. Coprescription of tamoxifen and medications that inhibit CYP2D6. J Clin Oncol. 2010; 28: 2768–2776. Review. 14. Lichtman SM, Wildiers H, Launay-Vacher V, et al. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer. 2007; 43: 14. 15. Chen RC, Royce TJ, Extermann M, Reeve BB. Impact of age and comorbidity on treatment and outcomes in elderly cancer patients.
Harrisons Manual of Oncology by Bruce Chabner, Jr., Thomas Lynch, Dan Longo